Led by Dr. Paraic Kenny, our team applies genomics, molecular biology, and translational research to drive advances in solid tumor oncology — from biobank-scale discovery to clinical precision medicine.
Ongoing Impact
Managing the Gundersen Cancer Biobank with 140,000+ specimens.
Utilizing high-throughput genomic sequencing to identify novel drivers in solid tumor development.
Learn moreContributing to Wisconsin's Molecular Tumor Board to translate data into life-saving clinical decisions.
Clinical workThe KCRI houses the CAP-accredited Gundersen Cancer Biobank with over 140,000 specimens.
Biobank access